Steroid study reveals brain changes in just 3 days
NCT ID NCT03896659
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a short course of corticosteroids (hydrocortisone) affects memory and brain areas involved in learning. Researchers gave 66 healthy adults and people with depression either the steroid or a placebo for three days, then used memory tests and advanced MRI scans to see changes. The goal was to understand which parts of the hippocampus are most sensitive to steroids and whether people with depression respond differently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
66 people
The number who actually took part.
- Started
-
Oct 2019
- Finished
-
Sep 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Men and women age 18-50 years with vision corrected to at least 20-40 (needed for fMRI tasks) * Education of ≥ 12 years * Baseline RAVLT total words recalled T-score ≥ 40 (normal range) * BMI between 18.5-35.0 (neither underweight nor severely obese) * Baseline QIDS-C ≤ 5 (virtual absence of depressive symptoms) for "healthy controls" and for the "depressed" group a QIDS-C between 11-20 (≥ moderate depressive symptoms but \< very severe depressive symptoms) Exclusion Criteria: * History of major psychiatric illness other than MDD for the depressed group, defined as bipolar disorder, posttraumatic stress disorder, schizoaffective disorder, schizophrenia, eating disorders, or MDD with psychotic features. For the control group, a past episode of MDD (per SCID) is also exclusionary * History of drug or alcohol use disorder * History of neurological disorders including seizures, brain surgery, multiple sclerosis, Parkinson's disease * Taking CNS-acting medications (e.g., antidepressants, antipsychotics, lithium, anticonvulsants, sedative/hypnotic/anxiolytics). Thus, the depressed group will be medication free. * History of allergic reaction or medical contraindication to hydrocortisone * Metal implants, claustrophobia, or other contraindications to MRI * Significant medical conditions (e.g., cancer, heart disease, diabetes) * Vulnerable population including pregnant or nursing women, prisoners, and people with intellectual disability, history of special education classes, dementia, or other severe cognitive disorders * Current suicidal ideation, a suicide attempt in the past 12 months or more than one lifetime attempt * History of systemic CS use in the past 12 months, lifetime cumulative use of more than 12 weeks, or recent (defined as past 28 days) inhaled CS use * Women who are using estrogen containing oral contraceptive agents (other contraceptives are acceptable, see Protection of Human Subjects section for a list of acceptable birth control methods) or who are post- or peri-menopausal or with irregular menstrual cycles (i.e., inconsistent menstruation patterns)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Reading the Brain's signals to predict who benefits from deep brain stimulation
- New sedative candidate goes Head-to-Head with propofol in early human test
- Can a phone app that blocks distracting apps ease depression?
- Can a Room-Temperature dairy drink build muscle?
- Can teachers and a phone app ease teen depression?
- Can imagining exercise boost brain power after spinal cord injury?